Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 3/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | MPO | P05164 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | KDM5A | P29375 | 1/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | ABL1 | P00519 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ALPI | P09923 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4658683 | 1.00 | BLM (0.47) | BLMPMP22KMT2AALOX15PDPK1 | |
| SCHEMBL29634956 | 0.84 | BLM (0.53) | BLMPMP22KMT2AALOX15NPC1 | |
| SCHEMBL9327656 | 0.81 | BLM (0.47) | BLMPMP22PDPK1CA2NPC1 | |
| SCHEMBL1970885 | 0.81 | BLM (0.47) | BLMPMP22KMT2AALOX15CA2 | |
| SCHEMBL7094989 | 0.81 | KDM4E (0.50) | BLMPMP22KMT2AALOX15CA2 | |
| SCHEMBL7094986 | 0.81 | KDM4E (0.50) | BLMPMP22KMT2AALOX15CA2 | |
| SCHEMBL2912663 | 0.78 | ESR1 (0.40) | BLMPMP22KMT2AALOX15CA2 | |
| SCHEMBL8107388 | 0.78 | ESR1 (0.40) | BLMPMP22KMT2AALOX15CA2 | |
| SCHEMBL2574988 | 0.76 | PDPK1 (0.46) | BLMPMP22PDPK1CA2NPC1 | |
| SCHEMBL2574989 | 0.76 | PDPK1 (0.46) | BLMPMP22PDPK1CA2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11904014-B2 | Immunostimulatory compositions | Assistance Publique—Hopitaux de Paris (FR) | 2024-02-20 | — | — | US | disclosed |
| EP-3380120-B1 | IMMUNOSTIMULATORY COMPOSITIONS | HOPITAUX PARIS ASSIST PUBLIQUE (FR) | 2021-04-21 | — | — | EP | disclosed |
| US-20210060156-A1 | IMMUNOSTIMULATORY COMPOSITIONS | ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (FR) | 2021-03-04 | — | — | US | disclosed |
| EP-3173098-A1 | IMMUNOSTIMULATORY COMPOSITIONS | ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (FR) | 2017-05-31 | — | — | EP | disclosed |
| EP-2001854-A2 | PHYTONUTRIENT COMPOSITIONS FROM MUSHROOMS OR FILAMENTOUS FUNGI AND METHODS OF USE | THE PENN STATE RESEARCH FOUNDATION (US) | 2008-12-17 | — | — | EP | disclosed |
| WO-2007106859-A2 | PHYTONUTRIENT COMPOSITIONS FROM MUSHROOMS OR FILAMENTOUS FUNGI AND METHODS OF USE | THE PENN STATE RESEARCH FOUNDATION (US) | 2007-09-20 | — | — | WO | disclosed |
| EP-0547065-B1 | MELANIN PRODUCTION BY TRANSFORMED MICROORGANISMS | LARGE SCALE BIOLOGY CORP (US) | 2001-08-29 | — | — | EP | disclosed |
| US-5837505-A | TRANSFORMATION OF MICROORGANISMS WITH VECTORS FORMING DNA SEQUENCES | BIOSOURCE TECHNOLOGIES, INC. (US) | 1998-11-17 | — | — | US | disclosed |
| US-5814495-A | GROWING IN A CASEIN, COPPER SULFATE, DISSOLVED OXYGEN AND TYROSINE MEDIUM | BIOSOURCE TECHNOLOGIES, INC. (US) | 1998-09-29 | — | — | US | disclosed |
| US-5631151-A | STREPTOMYCES | BIOSOURCE TECHNOLOGIES, INC. (US) | 1997-05-20 | — | — | US | disclosed |
| EP-0363792-B1 | Melanin production | BIOSOURCE GENETICS CORP (US) | 1995-01-18 | — | — | EP | disclosed |
| EP-0363792-A1 | Melanin production | BIOSOURCE GENETICS CORPORATION (US) | 1990-04-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210060156-A1 | IMMUNOSTIMULATORY COMPOSITIONS | CD47, CD74, LY96 | BLM 1393/4885PMP22 2639/4885KMT2A 2298/4885 |
| US-11904014-B2 | Immunostimulatory compositions | CD47, CD74, LY96 | BLM 1393/4885PMP22 2639/4885KMT2A 2298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.